This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...
Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of ...
A new study provides the first direct biological evidence explaining why some people continue to experience taste loss long after recovering from COVID-19.
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...
Contributed by Rafi Ahmed; received January 15, 2024; accepted July 2, 2025; reviewed by Stephen C. Jameson and Robert Seder CD45 isoforms are used to distinguish between naïve (CD45RA) and effector T ...
A UCLA-led international research team showed that fragments of digested proteins from the virus behind COVID-19 can attack certain immune cells that have spiky shapes, such as the T cell above. New ...
I am lying under a blanket, feeling rough, staring at a bowl of oranges. Every fibre of my being is urging me to devour the lot. I can hear my mum – and medical friends at university – insisting that ...
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...
Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...
Discover the nuances of CAR T-cell therapy eligibility and its advantages over traditional chemotherapy for long-term patient outcomes. Manali Kamdar, MD, MBBS, University of Colorado Anschutz, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results